Investigating how glutamine metabolism affects immune cell development in soft-tissue sarcomas
The Role of Glutamine Metabolism in Monocyte-Derived Dendritic Cell Differentiation in the Soft-Tissue Sarcoma Microenvironment
This study is looking at how a nutrient called glutamine affects certain immune cells in soft-tissue sarcoma, with the goal of finding new ways to boost the immune response and improve treatment options for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10888984 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of glutamine metabolism in the differentiation of immune cells called monocyte-derived dendritic cells (Mo-DCs) within the soft-tissue sarcoma (STS) microenvironment. The study aims to uncover the mechanisms that inhibit Mo-DC differentiation, which is crucial for enhancing the effectiveness of immunotherapy in treating STS. By exploring how glutamine is utilized by these immune cells, the research seeks to identify potential therapeutic strategies that could improve patient outcomes. Patients may benefit from insights that could lead to novel treatments targeting the immune response in STS.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with soft-tissue sarcomas who may be eligible for immunotherapy.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with soft-tissue sarcomas may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy strategies for patients with soft-tissue sarcomas.
How similar studies have performed: Previous research has shown promise in enhancing immune responses through metabolic interventions, suggesting potential success for this approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lobel, Graham — University of Pennsylvania
- Study coordinator: Lobel, Graham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.